BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of non-small cell lung cancer ...

The relationship between gut microbiota, immunoglobulin A, and vaccine efficacy Date: March 13, 2025 Source: IMIM (Hospital del Mar Medical Research Institute) Summary: A study has established the ...

Nanobodies, or single-domain antibodies, are only about 10% the sizeof traditional antibodies ... harnesses cutting-edge genetic engineering technologies to remove competing conventional antibodies ...